tradmap

TGTX Tg Therapeutics, Inc.

$53.23 +3.38%

Healthcare · Pharmaceutical Preparations

Tg Therapeutics, Inc. (TGTX) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $8.1 billion. Shares last traded at $53.23, near their 52-week high. Over the past year the stock is up 51.5%. TGTX trades at a price-to-earnings ratio of 18.22, above the Pharmaceutical Preparations median of 16.82. Net profit margin is 72.6%, above the peer median of -0.1%. Revenue grew 87.3% year over year.

Market Cap
$8.1B
Shares Out
153.1M
EPS (TTM)
$2.97
P/E Ratio
17.92
P/S Ratio
13.22
P/B Ratio
13.97
Dividend / Share
Dividend Yield
52-Week High
$54.05
52-Week Low
$25.36
Volume
109,594
Avg Vol (3m)
104,619.46

Performance

1W
+10.83%
1M
+34.96%
3M
+75.33%
6M
+72.97%
YTD
+82.11%
1Y
+51.52%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
82.97
SMA (50)
$39.74
SMA (200)
$33.66
Price vs SMA50
+33.96%
Price vs SMA200
+58.15%
ATR (14)
$2.89

Financials

Revenue
$616M
Net Income
$447M
Gross Margin
Operating Margin
20.0%
Net Margin
72.6%
Return on Equity
76.7%
Return on Assets
29.3%
Current Ratio
5.81
Debt / Equity
1.28
Revenue Growth (YoY)
+87.3%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

PeriodEPS (diluted)Reported
Q1 2026 $0.12 2026-05-06
FY 2025 $2.77 2026-02-27
Q3 2025 $2.62 2025-11-05
Q2 2025 $0.20 2025-08-08
Q1 2026 $0.03 2026-05-06
FY 2025 $0.15 2026-02-27

Full earnings history →

Pharmaceutical Preparations peers

TGTX vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/E vs peers
18.22 / 16.82 med
+8% premium
P/S vs peers
13.22 / 3.54 med
+274% premium
Net margin vs peers
72.6% / -0.1% med
above median
1–14 of 14
LLYLilly (Eli)$1.04T50.1615.8831.7%-1.17%
JNJJohnson & Johnson$549.8B20.515.8428.5%-2.42%
ONCBeone Medicines Ltd.$390.6B1361.2673.105.4%+2.83%
ABBVAbbVie$382.5B90.516.256.9%-2.16%
MRKMerck$281.6B15.434.3328.1%-1.30%
ABTAbbott Laboratories$154.3B23.653.4814.7%+0.09%
PFEPfizer$143.7B18.502.3012.4%-2.89%
VRTXVertex Pharmaceuticals$114.6B28.999.5532.9%-1.63%
BMYBristol Myers Squibb$110.3B15.632.2914.6%-2.35%
REGNRegeneron Pharmaceuticals$63.4B14.084.4231.4%+0.38%
ALNYAlnylam Pharmaceuticals$36.9B117.579.938.4%-1.66%
TEVATeva Pharmaceutical Industries Ltd$36.6B25.982.128.2%-3.33%
ZTSZoetis$33.1B12.373.4928.2%+2.09%
RPRXRoyalty Pharma Plc$23.1B30.029.7332.4%-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.